The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Dobrynina L.A.

Nauchnyĭ tsentr nevrologii RAMN, Moskva

Gnedovskaya E.V.

Federal State budgetary scientific Institution «Research Centre of Neurology», Moscow

Shabalina A.A.

Nauchnyĭ tsentr nevrologii RAMN, Moskva

Sergeeva A.N.

Research Center of Neurology, Moscow, Russia

Kravchenko M.A.

FGBU "Nauchnyĭ tsentr nevrologii" RAMN, Moskva

Nikolaeva N.S.

Research Center of Neurology, Moscow, Russia

Biomarkers and mechanisms of early vascular damage

Authors:

Dobrynina L.A., Gnedovskaya E.V., Shabalina A.A., Sergeeva A.N., Kravchenko M.A., Nikolaeva N.S.

More about the authors

Read: 1994 times


To cite this article:

Dobrynina LA, Gnedovskaya EV, Shabalina AA, Sergeeva AN, Kravchenko MA, Nikolaeva NS. Biomarkers and mechanisms of early vascular damage. S.S. Korsakov Journal of Neurology and Psychiatry. 2018;118(12‑2):23‑32. (In Russ.)
https://doi.org/10.17116/jnevro201811812223

Recommended articles:
Animal expe­rimental models in the study of age-dependent cere­bral microangiopathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3-2):57-68
Inflammatory aging. Part 2. Are there diagnostic biomarkers available. Russian Journal of Preventive Medi­cine. 2025;(1):89-95
The level of hypo­xia-induced factor-1a and asso­ciated mole­cules in preeclampsia. Russian Bulletin of Obstetrician-Gynecologist. 2025;(1):5-10
Personal characteristics of patients with cere­bral microangiopathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):51-56

References:

  1. Kotsis V, Antza C, Doundoulakis I, Stabouli S. Markers of Early Vascular Ageing. Curr Pharm Des. 2017;23(22):3200-3204. https://doi.org/1381612823666170328142433
  2. Nilsson PM, Boutouyrie P, Laurent S. Vascular aging: A tale of EVA and ADAM in cardiovascular risk assessment and prevention. Hypertens (Dallas, Tex 1979). 2009;54(1):3-10. https://doi.org/10.1161/HYPERTENSIONAHA.109.129114
  3. Kotsis V, Stabouli S, Karafillis I, Nilsson P. Early vascular aging and the role of central blood pressure. J Hypertens. 2011;29(10):1847-1853. https://doi.org/10.1097/HJH.0b013e32834a4d9f
  4. Kotsis V, Antza C, Stabouli S. Pathophysiology of Early Vascular Ageing-Opportunities for Treatment. Open Hypertens J. 2013;5:58-62. https://doi.org/10.2174/1876526201305010058
  5. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a «set up» for vascular disease. Circulation. 2003;107(1):139-146. https://doi.org/10.1161/01.cir.0000048892.83521.58
  6. Franklin SS, Khan SA, Wong ND, Larson MG, Levy D. Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study. Circulation. 1999;100(4):354-360. https://doi.org/10.1161/01.cir.100.4.354
  7. Franklin SS, Larson MG, Khan SA, Wong ND, Leip EP, Kannel WB, Levy D. Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation. 2001;103(9):1245-1249. https://doi.org/10.1161/01.cir.103.9.1245
  8. Wang M, Jiang L, Monticone RE, Lakatta EG. Proinflammation: The Key to Arterial Aging. Trends Endocrinol Metab. 2014;25(2):72-79. https://doi.org/10.1016/j.tem.2013.10.002
  9. Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol. 1994;24(6):1468-1474. https://doi.org/10.1016/0735-1097(94)90141-4
  10. Halcox JPJ, Donald AE, Ellins E, Witte DR, Shipley MJ, Brunner EJ, Marmot MG, Deanfield JE. Endothelial function predicts progression of carotid intima-media thickness. Circulation. 2009;119(7):1005-1012. https://doi.org/10.1161/CIRCULATIONAHA.108.765701
  11. Wu JT, Wu LL. Association of Soluble Markers with Various Stages and Major Events of Atherosclerosis. Annals of Clinical and Laboratory Science. 2005;35(3):240-250. https://doi.org/10.1016/j.atherosclerosis.2004.01.006
  12. Willeit P, Thompson SG, Agewall S, Bergström G, Bickel H, Catapano AL, Chien KL, de Groot E, Empana JP, Etgen T, Franco OH, Iglseder B, Johnsen SH, Kavousi M, Lind L, Liu J, Mathiesen EB, Norata GD, Olsen MH, Papagianni A, Poppert H, Price JF, Sacco RL, Yanez DN, Zhao D, Schminke U, Bülbül A, Polak JF, Sitzer M, Hofman A, Grigore L, Dörr M, Su TC, Ducimetière P, Xie W, Ronkainen K, Kiechl S, Rundek T, Robertson C, Fagerberg B, Bokemark L, Steinmetz H, Ikram MA, Völzke H, Lin HJ, Plichart M, Tuomainen TP, Desvarieux M, McLachlan S, Schmidt C, Kauhanen J, Willeit J, Lorenz MW, Sander D. Inflammatory markers and extent and progression of early atherosclerosis: Meta-analysis of individual-participant-data from 20 prospective studies of the PROG-IMT collaboration. Eur J Prev Cardiol. 2016;23(2):194-205. https://doi.org/10.1177/2047487314560664
  13. Tanashyan MM, Raskurazhev AA, Shabalina AA, Lagoda OV, Gnedovskaya EV. Biomarkery tserebral’nogo ateroskleroza: vozmozhnosti rannei diagnostiki i prognozirovaniya indiviudal’nogo riska. Annaly klinicheskoli i eksperimental’noi nevrologii. 2015;9(3):20-25. (In Russ.)
  14. Tanashyan MM, Lagoda OV, Gulevskaya TS, Maksyutina LN, Raskurazhev AA. Progressiruyushchii tserebral’nyi ateroskleroz: klinicheskie, biokhimicheskie i morfologicheskie aspekty. Annaly klinicheskoli i eksperimental’noi nevrologii. 2013;7(4):4-9. (In Russ.)
  15. Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, Lindley RI, O’Brien JT, Barkhof F, Benavente OR, Black SE, Brayne C, Breteler M, Chabriat H, DeCarli C, de Leeuw FE, Doubal F, Duering M, Fox NC, Greenberg S. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12(8):822-838. https://doi.org/10.1016/S1474-4422(13)70124-8.
  16. Dobrynina LA, Gnedovskaya EV, Sergeeva AN, Krotenkova MV, Piradov MA. MRT izmeneniya golovnogo mozga pri asimptomnoi vpervye diagnostirovannoi arterialnoi gipertenzii. Annaly Nevrologii. 2016;10(3):25-32. (In Russ.)
  17. Dobrynina LA, Gnedovskaya EV, Sergeeva AN, Krotenkova MV, Piradov MA. Subklinicheskie tserebralnye proyavleniya i porazhenie golovnogo mozga pri asimptomnoi vpervye diagnostirovannoi arterialnoi gipertenzii. Annaly Nevrologii. 2016;10(3):33-39. (In Russ.)
  18. Gorelick PB, Black SE, Greenberg SM, Launer LJ, Lopez OL, Petersen RC, Tzourio C, Bennett D, Higashida RT, Nilsson PM, Sellke FW, Scuteri A, Decarli C, Iadecola C, Laurent S, Nyenhuis D, Schneider JA, Arnett DK, Chui H, Lindquist R, Roman GC, Seshadri S. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke. 2011;42(9):2672-2713. https://doi.org/10.1161/STR.0b013e3182299496
  19. Poggesi A, Pasi M, Pescini F, Pantoni L, Inzitari D. Circulating biologic markers of endothelial dysfunction in cerebral small vessel disease: A review. J Cereb Blood Flow Metab. 2016;36(1):72-94. https://doi.org/10.1038/jcbfm.2015.116
  20. Markus HS, Hunt B, Palmer K, Enzinger C, Schmidt H, Schmidt R. Markers of endothelial and hemostatic activation and progression of cerebral white matter hyperintensities: longitudinal results of the Austrian Stroke Prevention Study. Stroke. 2005;36(7):1410-1414. https://doi.org/10.1161/01.STR.0000169924.60783.d4
  21. Kim Y, Kim Y-K, Kim NK, Kim S-H, Kim O-J, Oh S-H. Circulating matrix metalloproteinase-9 level is associated with cerebral white matter hyperintensities in non-stroke individuals. Eur Neurol. 2014;72(3-4):234-240. https://doi.org/10.1159/000362876
  22. Kario K, Matsuo T, Kobayashi H, Hoshide S, Shimada K. Hyperinsulinemia and hemostatic abnormalities are associated with silent lacunar cerebral infarcts in elderly hypertensive subjects. J Am Coll Cardiol. 2001;37(3):871-877. https://doi.org/10.1016/S0735-1097(00)01172-4.
  23. Scrivo R, Vasile M, Bartosiewicz I, Valesini G. Inflammation as «common soil» of the multifactorial diseases. Autoimmun Rev. 2011;10(7):369-374. https://doi.org/10.1016/j.autrev.2010.12.006.
  24. Inoue N. Stress and atherosclerotic cardiovascular disease. J Atheroscler Thromb. 2014;21(5):391-401. https://doi.org/10.5551/jat.21709
  25. Liu Y-Z, Wang Y-X, Jiang C-L. The common pathway of stress-related diseases. Front Hum Neurosci. 2017;11:10. https://doi.org/10.3389/fnhum.2017.00316
  26. Touboul P-J, Amarenco P, Csiba L, Ebrahim S, Hernández-Hernández R, Kownator S, Rundek T, Schminke U, Taylor A, Woo K, Zureik M, Hennerici M, Adams H, Bornstein NM, Desvarieux M, Fatar M, Jaff M, Prati P, Sitzer M, Tardif J-C, Vicaut E, Zannad F. Mannheim carotid intima-media thickness consensus (2004—2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis. 2007;23(1):75-80. https://doi.org/10.1159/000097034
  27. Pantoni L, Fierini F, Poggesi A. Impact of cerebral white matter changes on functionality in older adults: An overview of the LADIS Study results and future directions. Geriatr Gerontol Int. 2015;15(suppl 1):10-16. https://doi.org/10.1111/ggi.12665
  28. Yu S, Wong SL, Lau CW, Huang Y, Yu C-M. Oxidized LDL at low concentration promotes in-vitro angiogenesis and activates nitric oxide synthase through PI3K/Akt/eNOS pathway in human coronary artery endothelial cells. Biochem Biophys Res Commun. 2011;407(1):44-48. https://doi.org/10.1016/j.bbrc.2011.02.096
  29. El Samahy MH, Matter RM, Youssef OI, El Din El Telbany SMA, Kamal NA. Relation between carotid intima media thickness and oxidative stress markers in type 1 diabetic children and adolescents. J Diabetes Metab Disord. 2013;12:50. https://doi.org/10.1186/2251-6581-12-50.
  30. Chalew SA, Zadik Z, Lozano RA, Nelson JC, Kowarski AA. Plasma cortisol levels increase with age in obese subjects. Obes Res. 1993;1(3):199-202. https://doi.org/10.1002/j.1550-8528.1993.tb00612.x
  31. Gruys E, Toussaint MJM, Niewold TA, Koopmans SJ. Acute phase reaction and acute phase proteins. J Zhejiang Univ Sci B. 2005;6(11):1045-1056. https://doi.org/10.1631/jzus.2005.B1045
  32. Wilson PWF, Pencina M, Jacques P, Selhub J, D’Agostino RS, O’Donnell CJ. C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study. Circ Cardiovasc Qual Outcomes. 2008;1(2):92-97. https://doi.org/10.1161/CIRCOUTCOMES.108.831198
  33. Ridker PM. Inflammatory biomarkers and risks of myocardial infarction, stroke, diabetes, and total mortality: implications for longevity. Nutr Rev. 2007;65(12 Pt 2):253-259. https://doi.org/10.1111/j.1753-4887.2007.tb00372.x
  34. Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry. 2009;65(9):732-741. https://doi.org/10.1016/j.biopsych.2008.11.029
  35. Bradley JR. TNF-mediated inflammatory disease. J Pathol. 2008;214(2):149-160. https://doi.org/10.1002/path.2287
  36. Apostolaki M, Armaka M, Victoratos P, Kollias G. Cellular mechanisms of TNF function in models of inflammation and autoimmunity. Curr Dir Autoimmun. 2010;11:1-26. https://doi.org/10.1159/000289195
  37. Kollias G, Sfikakis PP. TNF Pathophysiology Molecular and Cellular Mechanisms. Curr Dir Autoimmun. 2010;11:1-26. https://doi.org/10.1159/isbn.978-3-8055-9384-7
  38. Schnoor M, Alcaide P, Voisin M-B, van Buul JD. Crossing the Vascular Wall: Common and Unique Mechanisms Exploited by Different Leukocyte Subsets during Extravasation. Mediators Inflamm. 2015;2015:946509. https://doi.org/10.1155/2015/946509
  39. Shibuya M. VEGF-VEGFR system as a target for suppressing inflammation and other diseases. Endocr Metab Immune Disord Drug Targets. 2015;15(2):135-144. https://doi.org/10.2174/1871530315666150316121956
  40. Huang J-L, Zhang Y-L, Wang C-C, Zhou J-R, Qian M, Wang X, Shen X-H, Jiang C-L. Enhanced phosphorylation of MAPKs by NE promotes TNF-alpha production by macrophage through alpha adrenergic receptor. Inflammation. 2012;35(2):527-534. https://doi.org/10.1007/s10753-011-9342-4
  41. Wang Y-L, Han Q-Q, Gong W-Q, Pan D-H, Wang L-Z, Hu W, Yang M, Li B, Yu J, Liu Q. Microglial activation mediates chronic mild stress-induced depressive- and anxiety-like behavior in adult rats. J Neuroinflammation. 2018;15(1):21. https://doi.org/10.1186/s12974-018-1054-3
  42. Sawant DA, Wilson RL, Tharakan B, Stagg HW, Hunter FA, Childs EW. Tumor necrosis factor-alpha-induced microvascular endothelial cell hyperpermeability: role of intrinsic apoptotic signaling. J Physiol Biochem. 2014;70(4):971-980. https://doi.org/10.1007/s13105-014-0366-8
  43. Wiseman S, Marlborough F, Doubal F, Webb DJ, Wardlaw J. Blood markers of coagulation, fibrinolysis, endothelial dysfunction and inflammation in lacunar stroke versus non-lacunar stroke and non-stroke: systematic review and meta-analysis. Cerebrovasc Dis. 2014;37(1):64-75. https://doi.org/10.1159/000356789
  44. Meng X-M, Nikolic-Paterson DJ, Lan HY. TGF-beta: the master regulator of fibrosis. Nat Rev Nephrol. 2016;12(6):325-338. https://doi.org/10.1038/nrneph.2016.48
  45. Samuel CS, Hewitson TD. Editorial: Novel therapeutic targets and emerging treatments for fibrosis. Front Pharmacol. 2017;8:10. https://doi.org/10.3389/fphar.2017.00824.
  46. Fang L, Murphy AJ, Dart AM. A Clinical Perspective of Anti-Fibrotic Therapies for Cardiovascular Disease. Front Pharmacol. 2017;8:186. https://doi.org/10.3389/fphar.2017.00186
  47. Ramakrishnan S, Anand V, Roy S. Vascular endothelial growth factor signaling in hypoxia and inflammation. J Neuroimmune Pharmacol. 2014;9(2):142-160. https://doi.org/10.1007/s11481-014-9531-7
  48. Shibuya M. Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases. J Biochem. 2013;153(1):13-19. https://doi.org/10.1093/jb/mvs136
  49. Liu F, Mu J, Yuan Z, Lian Q, Zheng S, Wu G, Liu E Involvement of the lymphatic system in salt-sensitive hypertension in humans. Med Sci Monit. 2011;17(10):542-546. https://doi.org/10.12659/MSM.881978
  50. Kuriyama N, Mizuno T, Kita M, Yamada K, Ozaki E, Matsumoto S, Takada A, Watanabe A, Kasai T, Nagakane Y, Mitani S, Matsui D, Watanabe I, Takeda K, Nakagawa M WY. TGF-beta1 is associated with the progression of intracranial deep white matter lesions: a pilot study with 5 years of magnetic resonance imaging follow-up. Neurol Res. 2014;36(1):47-52. https://doi.org/10.1179/1743132813Y.0000000256

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.